Janux Therapeutics Inc (JANX) — Cash Flow Reinvestment Rate
Latest as of March 2021:
25.65x
Janux Therapeutics Inc (JANX) has a Cash Flow Reinvestment Rate of 25.65x as of March 2021, reinvesting $142.67 Million (capex $153.00K plus investments $-142.52 Million) from operating cash flow of $5.56 Million. Explore cash efficiency ratio of Janux Therapeutics Inc to assess how effectively this company generates cash.
Reinvestment Rate
25.65x
(Capex + Investments) / Operating CF
Total Reinvested
$142.67 Million
Capex + Investments
Operating Cash Flow
$5.56 Million
USD
Capital Expenditures
$153.00K
USD
Annual Cash Flow Reinvestment Rate for Janux Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for Janux Therapeutics Inc. For live market cap and broader valuation context, see JANX company net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow